Chemotherapy for skull base cancers

被引：21

作者：

Diaz, EM

Kies, MS

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA

[2] Univ Texas, MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA

来源：

OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA | 2001年 / 34卷 / 06期

关键词：

D O I：

10.1016/S0030-6665(05)70366-2

中图分类号：

R76 [耳鼻咽喉科学];

学科分类号：

100213 ;

摘要：

This article focuses on treatment options for select skull base problems that have decreased post-treatment morbidity and, in many cases, improved survival. The select skull base cancers covered include nasopharyngeal carcinoma, squamous cell carcinoma of the paranasal sinuses, sinonasal undifferentiated carcinoma, neuroendocrine carcinoma, esthesioneuroblastoma, and salivary gland carcinoma.

引用

页码：1079 / +

页数：8

共 31 条

[1] Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer [J].

Brizel, DM ;

Albers, ME ;

Fisher, SR ;

Scher, RL ;

Richtsmeier, WJ ;

Hars, V ;

George, SL ;

Huang, AT ;

Prosnitz, LR .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (25) :1798-1804

[2] Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma [J].

Calais, G ;

Alfonsi, M ;

Bardet, E ;

Sire, C ;

Germain, T ;

Bergerot, P ;

Rhein, B ;

Tortochaux, J ;

Oudinot, P ;

Bertrand, P .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (24) :2081-2086

[3] Concomitant infusion cisplatin and hyperfractionated radiotherapy for locally advanced nasopharyngeal and paranasal sinus tumors [J].

Choi, KN ;

Rotman, M ;

Aziz, H ;

Sohn, CK ;

Schulsinger, A ;

Torres, C ;

HarEl, G ;

Chandra, P ;

Bradley, T ;

Rosenthal, CJ .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (04) :823-829

[4] PHARMACOLOGIC RATIONALE FOR REGIONAL DRUG DELIVERY [J].

COLLINS, JM .

JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (05) :498-504

[5] SINONASAL UNDIFFERENTIATED CARCINOMA - A RAY OF HOPE [J].

DEUTSCH, BD ;

LEVINE, PA ;

STEWART, FM ;

FRIERSON, HF ;

CANTRELL, RW .

OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1993, 108 (06) :697-700

[6]

FORASTIERE AA, 1987, CANCER CHEMOTH PHARM, V19, P155

[7]

Gallo O, 1993, Ear Nose Throat J, V72, P588

[8] Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial [J].

Jeremic, B ;

Shibamoto, Y ;

Milicic, B ;

Nikolic, N ;

Dagovic, A ;

Aleksandrovic, J ;

Vaskovic, Z ;

Tadic, L .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (07) :1458-1464

[9] Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer [J].

Kies, MS ;

Haraf, DJ ;

Rosen, F ;

Stenson, K ;

List, M ;

Brockstein, B ;

Chung, T ;

Mittal, BB ;

Pelzer, H ;

Portugal, L ;

Rademaker, A ;

Weichselbaum, R ;

Vokes, EE .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (07) :1961-1969

[10]

KUMAR P, 1999, P AN M AM SOC CLIN, pA396

← 1 2 3 4 →